Alpine Associates Management’s Seagen Inc. Common Stock SGEN Stock Holding History

Alpine Associates Management’s Portfolio SGEN Stock Details SGEN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-694,000	Closed	-$147M	–	41
2023 Q3	$147M	Buy	694,000 +19,400	+3%	+$3.88M	7.71%	3
2023 Q2	$130M	Buy	674,600 +302,000	+81%	+$60M	5.84%	5
2023 Q1	$75.4M	Buy	+372,600	New	+$59.8M	4.03%	9

Other funds holding SGEN

SCM

Segantii Capital Management Hong Kong $1.54B AUM 16.73% 1-Year Est. Return

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

BTI

Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return

FBC

Fairfield, Bush & Co Darien, Connecticut $180M AUM 39.51% 1-Year Est. Return

VWA

Valued Wealth Advisors Holladay, Utah $275M AUM 24.94% 1-Year Est. Return

SAG

Spotlight Asset Group Oakbrook Terrace, Illinois $143M AUM 20.66% 1-Year Est. Return

Alpine Associates Management's SGEN Position: Q4 2023 in Review

Alpine Associates Management sold out of Seagen Inc. Common Stock (SGEN) in Q4 2023, closing a stake of 694,000 shares — an estimated $147M sold.

Alpine Associates Management first reported a position in SGEN in Q1 2023 and held it in 3 quarters. The position peaked at $147M in Q3 2023. 6 funds tracked by Wall St. Rank hold SGEN as of Q4 2023.

Alpine Associates Management reported no remaining Seagen Inc. Common Stock position as of Q4 2023 after selling out during the quarter.
Alpine Associates Management sold 694,000 Seagen Inc. Common Stock shares in Q4 2023, an estimated $147M.
Alpine Associates Management first reported a position in Seagen Inc. Common Stock in Q1 2023 and held it in 3 quarters.
Alpine Associates Management's Seagen Inc. Common Stock position peaked at $147M in Q3 2023.
6 funds tracked by Wall St. Rank held Seagen Inc. Common Stock as of Q4 2023.

Based on Alpine Associates Management's 13F filing for Q4 2023, filed 7 Feb 2024.